-
ABOUT USAffiliated to SSY Group Limited, Hebei Guangxiang Technology Co., Ltd., is a high-tech enterprise specializing in drug research and technology development.
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the synergy between “industry, academia, research and application” based on multi-disciplinary integration and multi-directional combination.
-
SUBORDINATEThe group has decided to establish research institutes in its subsidiaries, Hebei Ghuangxiang Drug Research Institute, Jiangsu Best Medical Material Research Institute, and Hebei Hanlin Biological Research Institute.
-
RECRUITWe actively establish a joint talent cultivation mechanism between schools and enterprises, and currently have over 500 high-level talents in various fields such as drug research, analysis, and clinical practice.
-
CONTACTWe will continue to strengthen innovation-driven development, vigorously promote the integration of production and research, constantly improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs.
Taizhou City leader Zhang Xiaobing visited and conducted a research tour at Boshi Medical Devices Group.
Category:
Time：2023-04-04
On March 24, Zhang Xiaobing, a member of the Standing Committee of the Taizhou Municipal Party Committee, Head of the United Front Work Department of the Municipal Party Committee, and Deputy Secretary of the Party Group of the Municipal Political Consultative Conference, led a team to visit and conduct an in-depth investigation into the development status of Bosheng Medical Devices Group. Chen Jun, Deputy Director of the United Front Work Department of the Taizhou Municipal Party Committee and Party Secretary of the Municipal Federation of Industry and Commerce, along with Yin Xiaojian, a member of the Party Leadership Group and Vice Chairman of the Municipal Federation of Industry and Commerce, accompanied the inspection. Zhang Guozhen and Li Ligong, leaders of Bosheng Medical Devices Group, also joined the visit.
On March 24, Zhang Xiaobing, a member of the Standing Committee of the Taizhou Municipal Party Committee, head of the United Front Work Department of the Municipal Party Committee, and deputy secretary of the Party Group of the Municipal Political Consultative Conference, led a team to visit and conduct an in-depth investigation into the development status of Bosheng Medical Devices Group. Chen Jun, deputy director of the United Front Work Department of the Taizhou Municipal Party Committee and Party Secretary of the Municipal Federation of Industry and Commerce, along with Yin Xiaojian, a member of the Party Group and vice chairman of the Municipal Federation of Industry and Commerce, accompanied the inspection. Zhang Guozhen and Li Ligong, leaders of Bosheng Medical Devices Group, also joined the visit.
Zhang Xiaobing and his delegation paid a field visit to the multi-layer co-extruded film project for biological applications and listened carefully to the company’s briefing on its production and operations, market share, and technological innovation. They also asked about the current challenges and problems facing the company’s development and sought the company’s suggestions and advice on government support for healthy and high-quality development.
In recent years, Bosheng Medical Devices Group has been deeply engaged in the high-end, sophisticated pharmaceutical packaging materials sector, adhering to a development path characterized by “specialization, refinement, distinctiveness, and innovation.” The group has consistently focused on its core business, upheld independent innovation, and established an efficient and advanced R&D and innovation system for pharmaceutical packaging materials. As a result, it has developed a series of high-quality formulations and cutting-edge process technologies. Notably, Bosheng was among the first in China to master the patented vacuum deposition technology for poly-p-xylene coatings, as well as a new formulation and process for specialized stoppers used with cephalosporin antibiotics. Moreover, the company has successfully developed a range of coated stopper products that fill a domestic gap, and is currently the only enterprise in China capable of producing radiation-resistant sterilization stoppers. By actively exploring new technologies and concepts in the development of pharmaceutical packaging materials, Bosheng Medical Devices continues to demonstrate strong innovative vitality and resilient growth, emerging as a key driving force behind technological advancement and industrial development in the pharmaceutical packaging industry.
Zhang Xiaobing fully affirmed the remarkable achievements made by Bosheng Medical Devices in entering new growth areas and striving to become a specialized, refined, distinctive, and innovative enterprise. He took a close look at the issues that the company needs to coordinate and resolve during its R&D, production, and operations, and carefully listened to the company’s suggestions on government policies supporting the development of the pharmaceutical and greater health industry. Zhang Xiaobing pointed out that it is essential to step up publicity efforts for business-benefiting policies, bring these policies into chambers of commerce and enterprises, and ensure that businesses are fully informed and fully benefit from them. It is also important to optimize the mechanism for liaison and service, continuously build well-known brands such as the “Direct Channel for Business Appeals” and the “United Hearts to Boost” industrial transformation and upgrading center, improve the guarantee of resource factors, and help private enterprises achieve transformation, upgrading, and innovative development, thus fostering a synergistic effort toward shared development and joint innovation.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Mobile site
E code
Business license